SONEX RESEARCH INC
10QSB, 1998-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: IRONSTONE GROUP INC, 10QSB, 1998-08-14
Next: LETCHWORTH INDEPENDENT BANCSHARES CORP, 10QSB, 1998-08-14












                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549


                                   FORM 10-QSB


                  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended June 30, 1998.




                              SONEX RESEARCH, INC.



                      Incorporated in the State of Maryland
                                23 Hudson Street
                            Annapolis, Maryland 21401


                        Telephone Number: (410) 266-5556
                   IRS Employer Identification No. 52-1188993


                         Commission file number 0-14465






Check  whether the Issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the Exchange Act during the preceding 12 months, and (2) has been
subject to such filing requirements for the past 90 days.

                                            YES   [x]       NO   [ ]



There  were  17,594,355  shares  of the  Issuer's  $.01 par value  Common  Stock
outstanding at July 31, 1998.



























                                      - 1 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB







                         PART I - FINANCIAL INFORMATION





ITEM 1.  FINANCIAL STATEMENTS (Unaudited)


Index to unaudited financial statements presented on pages 3 to 9:

     Balance sheets as of June 30, 1998 and December 31, 1997

     Statements  of  operations  and  accumulated  deficit  for the  three- and 
     six- month periods  ended  June 30,  1998 and 1997,  and for the period 
     from April 9, 1980 (inception) through June 30, 1998

     Statements of paid-in capital for the period from January 1, 1996 through
     June 30, 1998

     Statements of cash flows for the six-month periods ended June 30, 1998
     and 1997, and for the period from April 9, 1980 (inception) through 
     June 30, 1998

     Notes to financial statements




















































                                      - 2 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                          (A Development Stage Company)
                            CONDENSED BALANCE SHEETS
                                   (Unaudited)


                                                       June 30,    December 31,
                           ASSETS                        1998         1997
                                                     ------------  ------------

Current assets
 Cash and equivalents                                $    265,608  $    355,582
 Marketable securities, available-
   for-sale                                               204,500       117,200
 Accounts receivable, including unbilled
   costs and estimated earnings on uncompleted                                
   contracts of $183,750 in 1997                          133,396       210,088
 Prepaid expenses                                          26,134        36,284
 Loans to officers and employees                           26,124        22,500 
                                                     ------------  ------------
   Total current assets                                   655,762       741,654

Patents and technology, net of accumulated
  amortization of $57,985 in 1998 and
  $50,785 in 1997                                         234,726       231,742

Property and equipment, net of accumulated
  depreciation of $404,173 in 1998 and
  $398,173 in 1997                                         20,634        17,206
                                                     ------------  ------------

           Total assets                              $    911,122  $    990,602
                                                     ============  ============


     Liabilities and Stockholders' Equity

Current liabilities
 Accounts payable and other accrued liabilities,
   including accrued subcontract costs on
   uncompleted contracts of $111,750 in 1997         $     47,085  $    147,220
 Accrued compensation                                     721,969       688,292
  
                                                     ------------  ------------
     Total current liabilities                            769,054       835,512
                                                     ------------  ------------

Stockholders' equity
 Preferred stock, $.01 par value - 2,000,000
   shares issued; 1,540,001 shares outstanding             15,400        15,400 
 Common stock, $.01 par value - shares issued
   and outstanding: 17,594,355 in 1998 and
   17,393,906 in 1997                                     175,944       173,939 
 Additional paid-in capital                            20,160,089    20,035,060
 Unrealized increase in value of
   marketable securities                                  204,500       117,200
 Deficit accumulated during development stage         (20,413,865)  (20,186,509)
                                                     ------------  ------------
   Total stockholders' equity                             142,068       155,090
                                                     ------------  ------------

   Total liabilities and stockholders' equity        $    911,122  $    990,602
                                                     ============  ============
















    The accompanying notes are an integral part of the financial statements.

                                      - 3 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                          (A Development Stage Company)
           CONDENSED STATEMENTS OF OPERATIONS AND ACCUMULATED DEFICIT
                                   (Unaudited)



                                                                   April 9, 1980
                                                                     (inception)
                        Three months ended      Six months ended       through
                              June 30,              June 30,           June 30,
                         1998        1997       1998         1997        1998
                      ----------  ----------  ----------  ----------  ----------

Revenue
 Development contracts $ 114,165  $  104,375  $  166,370  $  144,375  $2,130,104
 Subcontracts             29,900                  50,672                 170,092
 Other                                                                   124,425
                      ----------  ----------  ----------  ----------  ----------

                         144,065     104,375     217,042     144,375   2,424,621
                      ----------  ----------  ----------  ----------  ----------

Costs and expenses
 Research & develop.  $  159,837  $  130,986  $  288,125     249,967  12,638,341
 Cost of subcontracts     28,400                  47,620                 159,370
 General & administ.      75,793      78,820     148,391     142,568   7,662,638
 Interest                                286                     572     868,094
 Write-off of patents                                                    819,036
                      ----------  ----------  ----------  ----------  ----------
                         264,030     210,092     484,136     393,107  22,147,479
                      ----------  ----------  ----------  ----------  ----------

Net loss from
 operations              119,965     105,717     267,094     248,732  19,722,858

Other (income)/expense
 Investment income        (3,866)     (7,759)     (7,872)     (9,098)  (319,788)
 Debt issuance and
  conversion expense                                                   1,112,350
 Gain on sale of marketable
  securities             (31,866)     (8,121)    (31,866)     (8,121)  (101,555)
                      ----------  ----------  ----------  ----------  ----------

Net loss                  84,233      89,837     227,356     231,513  20,413,865

Accumulated deficit

 Beginning            20,329,632  19,798,189  20,186,509  19,656,513
                      ----------  ----------  ----------  ----------  ----------

 End                 $20,413,865 $19,888,026 $20,413,865 $19,888,026 $20,413,865
                      ==========  ==========  ==========  ==========  ==========




Net loss per share         $.005       $.005       $.013       $.014
                           =====       =====       =====       =====



Weighted average
 number of shares
 outstanding          17,581,658  17,174,825  17,528,812  16,816,347
                      ==========  ==========  ==========  ==========













    The accompanying notes are an integral part of the financial statements.

                                      - 4 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                          (A Development Stage Company)
                     CONDENSED STATEMENTS OF PAID-IN CAPITAL
                                   (Unaudited)


                          Price  Preferred stock    Common stock     Additional
                           per  ($.01 par value)  ($.01 par value)     paid-in
                          share  Shares   Amount   Shares    Amount    capital
                          ----- --------- ------ ---------- -------  ----------

Note: Retroactive effect has been given to all previously declared stock splits.

Balance, January 1, 1996        1,830,000$18,300 15,281,535$152,815 $19,078,191

January for services       1.00                       1,000      10         990
January through August -
 option exercises           .50                     131,488   1,315      64,429
April and July -
 conversion (.35 to 1)           (279,999)(2,800)   799,997   8,000      (5,200)
Compensation - stock options                                             27,125
                                --------- ------ ---------- -------  ----------

Balance, December 31, 1996      1,550,001 15,500 16,214,020 162,140  19,165,535

January through December
 option exercises           .50                     352,834   3,528     172,889
January through June
 option exercises           .75                      17,000     170      12,580
March for cash              .75                     775,519   7,755     573,884
October -
 conversion (.35 to 1)            (10,000)  (100)    28,571     286        (186)
December for services      1.00                       5,962      60       5,902
Compensation - stock options                                            104,456
                                --------- ------ ---------- -------  ----------
Balance, December 31, 1997      1,540,001 15,400 17,393,906 173,939  20,035,060

January through June
 option exercises           .50                     172,500   1,725      84,525
March for services          .625                     20,000     200      12,300
June - for services         .75                       7,949      80       5,882
Compensation - stock options                                             22,322
                                --------- ------ ---------- -------  ----------

Balance, June 30, 1998          1,540,001$15,400 17,594,355$175,944 $20,160,089
                                ========= ====== ========== ======= ===========

































    The accompanying notes are an integral part of the financial statements.

                                      - 5 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                          (A Development Stage Company)
                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

                                                                   April 9, 1980
                                                                    (inception)
                                              Six months ended        through
                                                   June 30,          June 30,
                                                1998       1997        1998
                                             ---------  ---------  ------------

Cash flows from operating activities
 Net loss                                    $(227,356) $(231,513) $(20,413,865)
 Adjustments to reconcile net loss to                                           
  net cash used by operating activities                                         
   Depreciation                                  6,000      6,750       685,262 
   Amortization of patents and technology        7,200     32,978     1,456,202 
   Write-down of patents and technology                                 819,036 
   Compensation - stock options                 22,322      1,500     1,004,443 
   Imputed interest expense                                             551,247 
   Interest credited to paid-in capital                                  44,614 
   Debt issuance and conversion expense                               1,112,350 
   Accrued liabilities and current                                              
    charges paid in stock                       18,462                1,148,804 
   Gain on sale of marketable securities       (31,866)    (8,121)     (101,555)
   (Increase)decrease in accounts receivable    76,692     50,000      (133,396)
   (Increase)decrease in prepaid expenses       10,150     (7,188)      (26,134)
   Increase (decrease)in accrued liabilities   (66,458)   (65,443)      681,390 
                                             ---------  ---------  ------------ 
Net cash used in operating activities         (184,854)  (221,037)  (13,171,602)
                                             ---------  ---------  ------------

Cash flows from investing activities
 Purchase of marketable securities                                   (2,377,256)
 Proceeds from sales of marketable securities   31,866      8,121     2,478,811
 (Increase) decrease in loans to employees      (3,624)       933       (26,124)
 Acquisition of property                        (9,428)                (556,409)
 Additions to patents and technology           (10,184)   (57,113)   (1,385,514)
                                             ---------  ---------  ------------
Net cash provided by (used for)
 investing activities                           (8,630)   (48,059)   (1,866,492)
                                             ---------  ---------  ------------

Cash flows from financing activities
 Issuance of stock                              86,250    696,139    15,964,711
 Issuance of convertible debt                                         2,287,500
 Indemnification by officer                                              15,000
 Repayment of convertible debt                                          (92,500)
 Stock and debt issuance costs                                       (2,038,916)
 Distribution to stockholders - other                                   (18,772)
 Reduction of technology purchase
  obligations                                                          (797,500)
 Proceeds from borrowings                                             1,592,748
 Reduction of borrowings                                             (1,608,569)
                                             ---------  ---------  ------------
Net cash provided by (used for)
 financing activities                           86,250    696,139    15,303,702
                                             ---------  ---------  ------------

Increase (decrease) in cash                    (89,974)   427,043       265,608

Cash
 Beginning of period                           355,582     89,739
                                             ---------  ---------  ------------
 End of period                               $ 265,608  $ 516,782  $    265,608
                                             =========  =========  ============












    The accompanying notes are an integral part of the financial statements.

                                      - 6 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                          (A Development Stage Company)
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                                   (Unaudited)


Note 1 - The Company
- --------------------

       Sonex Research, Inc. has developed a proprietary technology, known as the
Sonex Combustion System (SCS), which controls the combustion of fuel in engines.
The  Company  expects to license  several  applications  of its  technology  and
commercially exploit other applications  itself.  Related revenue earned to date
has been  derived  principally  from  development  contracts,  but such  revenue
historically  has  offset  only  a  small  portion  of the  related  development
expenditures.  Accordingly,  Sonex Research, Inc. is classified as a development
stage company.


Note 2 - Presentation of Financial Statements
- ---------------------------------------------

       The  accompanying  unaudited  condensed  financial  statements  have been
prepared in accordance with generally accepted accounting principles for interim
financial  information and with the  instructions to Form 10-QSB and Item 310(b)
of Regulation S-B. Accordingly, these financial statements do not include all of
the  information  and  footnotes  required  by  generally  accepted   accounting
principles for complete financial statements. In the opinion of management,  all
adjustments (consisting of normal recurring accruals) considered necessary for a
fair presentation  have been included.  Operating results for the three- and six
month periods ended June 30, 1998 are not necessarily  indicative of the results
that  may be  expected  for the year  ending  December  31,  1998.  For  further
information,  reference is made to the  financial  statements  and notes thereto
included  in the  Company's  Annual  Report on Form  10-KSB  for the year  ended
December 31, 1997.


Note 3 - Patents and Technology
- -------------------------------

       The costs associated with the filing of patent applications are deferred.
Amortization is recorded on a straight-line  basis over the remaining legal life
of patents, commencing in the year in which the patent is granted. Costs related
to patent applications which ultimately fail to result in the grant of a patent,
either through  rejection by patent  authorities  or through  abandonment by the
Company, are charged to operations at the time such determination is made.

       The  Company  continues  to  conduct  its own  research  and  development
activities which have resulted in additional proprietary technology and patents.
Development  of  commercial  applications  of  certain  elements  of the SCS has
commenced and management believes the capitalized cost of patents and technology
will be recovered through revenue derived from the licensing of such technology.
Management  closely  monitors the patent  application  process and other factors
which may  affect  the  economic  value of the  Company's  technology,  and will
further  reduce  the  capitalized  cost of  patents  and  technology  should the
recovery of such cost no longer be sustainable.


Note 4 - Accrued Compensation
- -----------------------------

       In order to help conserve the Company's  limited cash  resources,  all of
the Company's  employees for several years have voluntarily  deferred receipt of
payment  of  significant  portions  of their  authorized  annual  salaries  when
requested  by the Board of  Directors  to do so. From time to time,  portions of
such  deferred  amounts have been paid through the issuance to the  employees of
shares, or discounted options to purchase shares, of the Company's Common Stock.
Since  January 1, 1997,  however,  there has been no further  deferral of salary
requested of the  Company's  non-executive  employees.  As of June 30, 1998,  an
aggregate  of $661,492  of wages so  deferred  by current  and former  employees
remained  unpaid and has been recorded as accrued  compensation on the Company's
balance sheet.









                                      - 7 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


       As a  condition  of the  Company's  receiving  an  indispensable  capital
infusion in February 1992, the investors,  Proactive Partners,  L.P. and certain
of its affiliates  ("Proactive") who became the largest  beneficial owner of the
Company's common stock by virtue of the purchase of convertible  preferred stock
and common stock  purchase  warrants,  required that the  voluntary  deferral of
salaries  be  documented  formally.   Accordingly,  all  employees  executed  an
agreement  referred to as the "Consent to  Deferral" in which they  consented to
the past and future deferral of portions of their annual salaries, and agreed to
defer payment of amounts so accumulated until the Company has received licensing
revenue of at least $2 million or at such earlier date as the Board of Directors
determines that the Company's cash flow is sufficient to allow such payment. The
conditions  of the Consent to Deferral  that would allow  repayment  of deferred
salaries have yet to occur.


Note 5 - Income Taxes
- ---------------------

       The Company has not  incurred any federal or state income taxes since its
inception  due to operating  losses.  At December 31, 1997,  the Company had net
operating loss carryforwards of approximately  $16.8 million available to offset
future taxable income. If certain substantial changes in the Company's ownership
should  occur,  there  would  be an  annual  limitation  on  the  amount  of the
carryforwards   which  can  be  utilized.   The  Company's  net  operating  loss
carryforwards expire at various dates from 1998 through 2012, as follows:

              Expiring in 1998                           $    658,000
              Expiring in 1999                                900,000
              Expiring in 2000                              1,105,000
              Expiring in 2001                              1,749,000
              Expiring in 2002                              1,838,000
              Expiring in 2003 - 2012                      10,526,000
                                                         ------------

                                                         $ 16,776,000


Note 6 - Stockholders' Equity
- -----------------------------

Authorized capital stock

       The Company is presently  authorized  to issue 48 million  shares of $.01
par  value  common  stock and 2  million  shares  of $.01 par value  convertible
preferred stock. The preferred stock has priority in liquidation over the common
stock,  but it carries no stated  dividend.  The holders of the preferred stock,
voting as a separate class,  have the right to elect that number of directors of
the Company which  represents a majority of the total number of  directors.  The
preferred  stock is  convertible  at any time at the option of the  holder  into
common stock at the rate of $.35 per share of common stock. As of June 30, 1998,
a total of 459,999  shares of preferred  stock had been converted into 1,314,278
shares of common stock.


Stock options

       The Company  maintains a  non-qualified  stock  option plan (the  "Plan")
which has made  available for issuance a total of five million  shares of common
stock.  All directors,  full-time  employees and  consultants to the Company are
eligible for  participation.  Option awards are  determined at the discretion of
the Board of Directors. Upon a change in control of the Company, all outstanding
options  granted to employees and directors  become vested with respect to those
options which have not already  vested.  Options  outstanding  expire at various
dates through December 2007.

     The Company accounts for stock-based compensation using the intrinsic value
method prescribed in Accounting Principles Board (APB) Opinion No. 25. Under APB
No. 25,  compensation  cost is  measured  as the  excess,  if any, of the quoted
market price of the Company's stock at the date of grant over the exercise price
of the  option  granted.  Compensation  cost  for  stock  options,  if  any,  is
recognized  ratably over the vesting period.  In its complete  annual  financial
statements  presented in its Form 10-KSB,  the Company  provides  additional pro
forma disclosures as required under Statement of Financial  Accounting Standards
No. 123 - "Accounting for Stock-Based  Compensation"  as if the fair value based
method of accounting had been applied to the Company's  stock option grants made
subsequent to 1994.






                                      - 8 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


Common stock reserved for future issuance

       At June 30,  1998,  a total of  14,864,273  shares of common  stock were
reserved for issuance for the following purposes:


                         Purpose                                  # of shares
              -----------------------------                       -----------

Currently exercisable warrants:
 Exercisable at $.35 per share, expiring in February 2000            571,428
 Exercisable at $.375 per share, expiring in June 2000               595,000
 Exercisable at $.50 per share, expiring in June 2000                595,000
 Exercisable at $.75 per share, expiring on various dates
  from June 1999 through March 2002                                4,874,509
                                                                  ----------
                                                                   6,635,937
                                                                  ----------
Currently exercisable options:
 Exercisable at $.50 per share                                     3,116,466
 Exercisable at $.75 per share                                       173,500
 Exercisable at $1.00 per share                                       50,000
                                                                  ----------
                                                                   3,339,966
                                                                  ----------
Granted options becoming exercisable in the future:
 Exercisable at $.50 per share                                        83,750
 Exercisable at $.75 per share                                        22,500
                                                                  ----------
                                                                     106,250

Options available under plan for future grants                       382,117

Conversion of preferred stock                                      4,400,003
                                                                  ----------

 Total shares reserved                                            14,864,273
                                                                  ==========


Note 7 - Commitments
- --------------------

       The  Company   occupies   its  office  and   laboratory   facility  on  a
month-to-month  basis  under  the terms of an  operating  lease  agreement  that
expired in April 1994 and was subsequently extended twice, most recently through
November  1997.  No new  long-term  lease has been  negotiated  since  this last
extension  expired,  and the Company once again is  occupying  the premises on a
month-to-month  basis under the terms of the previous  lease,  pursuant to which
the  property  owner is required  to provide  thirty days notice if he wants the
Company to vacate the premises.  The lease  provides for monthly rent of $3,500,
and requires the Company to pay all property related expenses.  The Company will
seek to  negotiate  a new  long-term  lease for its  facility  or search  for an
alternative  location in the event that an  agreement  cannot be reached for the
existing  premises.  Management  believes that the resolution of the uncertainty
with respect to the facility  will not result in a significant  interruption  in
the operations of the Company.

























                                      - 9 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL POSITION
                         AND RESULTS OF OPERATIONS


Description of the business
- ---------------------------

       Sonex  Research,  Inc.  ("Sonex"  or the  "Company")  is  engaged  in the
research,  development and  commercialization  of a proprietary  technology (the
"Sonex Combustion  System",  "SCS" or "Ultra Clean Burn(TM)  technology")  which
controls the combustion of fuel in engines  through  modification of the pistons
in large engines or the cylinder heads in small  engines.  The Company has shown
through  tests  in  manufacturers'  engines  and in  computer  models  that  its
technology has the ability to control  combustion and allow fuel to be used more
efficiently,  and that engines using the Company's  technology have  performance
superior to conventional  engines and emit fewer harmful exhaust emissions.  The
SCS process,  which has no moving parts, produces lower overall emissions at all
engine speeds,  particularly  soot in diesel engines,  and is self-driven by the
combustion process.

       Management  believes that the Company's  technology can be applied to all
types of internal  combustion  engines,  including  those used in  personal  and
commercial vehicles (automobiles,  trucks, buses, boats and motorcycles) as well
as engines used in fixed or portable utility applications (motor generator sets,
pumps, and chain saws),  whether spark ignited (SI) or compression ignited (CI),
carburetted  or fuel injected,  using either  gasoline,  diesel,  alcohol and/or
other fuels.

       The Company's  competition comes from the extensive research  departments
of the world's major  vehicle and engine  manufacturers  as well as  independent
engine  testing firms.  Although the  experience and financial  resources of its
competitors  far exceed those of the Company,  management  believes that the SCS
can  provide   significant   advantages   over  the  competition  on  price  and
performance.  Due to the highly competitive nature of the world's automotive and
truck industries, in connection with its contracts and/or demonstration programs
with such  manufacturers  the Company is required to execute  joint  secrecy and
disclosure  agreements  that  expressly  prohibit the public  disclosure  of the
customers' names and other significant information. Failure by Sonex to maintain
this strict level of  confidentiality  would  jeopardize the relationship of the
Company with its customers.

       Over the past few  years,  Sonex  has  concentrated  its  efforts  on the
application  of its  technology  to direct  injected  (DI)  turbocharged  diesel
engines.  Demonstration and development programs at various stages of completion
are underway with some of the largest multi-national diesel engine manufacturers
in the world.  The goal of such programs is to execute broad agreements with the
diesel engine manufacturers and their piston suppliers for industrial production
of Sonex  pistons  under  license from the Company.  The  demonstration  process
involves  many stages,  from proof of concept  using  screw-assembled  prototype
pistons  fabricated  in-house by Sonex, to working with piston suppliers for the
fabrication of finished pre-production pistons that will be used in field trials
and durability,  manufacturing optimization, and other tests required before the
start of full series production.

       To date, the Company has completed separate  demonstration  programs with
three of these  manufacturers,  and each has verified and accepted  that the SCS
can  substantially  reduce  particulate  emissions at future NO (nitrous  oxide)
levels  in  a DI  turbocharged  diesel  engine  for  medium  duty  trucks  while
maintaining  fuel  consumption and power. The most recent tests conducted by one
of these manufacturers showed that an engine using Sonex- modified pistons along
with EGR  (exhaust  gas  recirculation)  would  attain  future U.S. and European
emissions   targets  when  OEM  type   production   pistons  become   available.
Negotiations  are underway with one of the world's largest piston  suppliers and
with  these  manufacturers  for  licensing,   technology  transfer  and  further
development programs. The Company is also participating with one of these engine
manufacturers,  its component suppliers, and an independent engine testing firm,
on an engine  application  program  aimed at  substantially  upgrading a current
production medium size truck diesel engine to meet future emissions standards.

     In  addition  to  diesel  truck  engine  applications,  the  Company  has
successfully applied a proprietary starting system and modified engine design to
the conversion of lightweight,  SI gasoline fueled engines of various sizes used
in small, remotely controlled military Unmanned Aerial Vehicles (UAV's) to start
and  operate on JP5/JP8  standard  military  fuels  (also  referred to as "heavy
fuels"). In January 1998 the Company delivered to the United States Marine Corps
(USMC) Systems  Command in Quantico,  Virginia,  five protoytpe UAV engines that
Sonex  successfully  converted  from gasoline to heavy fuel  operation,  and, in
February 1998 Sonex  received an order from the USMC Systems  Command to convert
an additional forty UAV gasoline engines to heavy fuel operation. The



                                     - 10 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


Company  is  also  performing  a  UAV  heavy  fuel  engine  conversion  under  a
demonstration  contract  awarded in October  1997 by the U.S.  Naval Air Warfare
Center, Aircraft Division, in Patuxent River, Maryland.

       In July 1998 the Company signed on as a subcontractor to Northrop Grumman
Corporation  (NGC),  whose  Military  Aircraft  Systems  Division in El Segundo,
California,  is currently in the process of  developing a UAV as a candidate for
application into various U.S.  Government and  international  programs.  Under a
purchase  order issued by NGC,  Sonex will convert a UAV engine from gasoline to
heavy fuel use.

Also in July  1998,  the  Company  was  awarded a Phase I Small  Business
Innovation  Research  (SBIR)  Program  contract  by the U.S.  Naval Sea  Systems
Command (NAVSEA) to investigate the feasibility of utilizing its proprietary SCS
to meet NAVSEA's objective of designing a low-cost, small, rugged engine capable
of starting and  operating  on  shipboard-safe  heavy fuels,  for use in a small
aircraft  that would be  suitable  for  launch  from guns and  missiles  and for
delivery by airdrop.  The aspects of the design  ruggedness and other  interface
requirements  for potential  transition  opportunities  will be performed  under
subcontract by Science Applications  International Corporation (SAIC) of McLean,
Virginia.  SAIC,  an advanced  technology  firm,  is one of the world's  leading
providers of information technology, network systems, data security, and systems
integration.  It has particular  expertise in current  national defense concepts
such as advanced sensor  technology,  automatic  target  recognition,  UAV's and
other  information  technologies.  In Phase I,  Sonex will  select a  commercial
gasoline  engine and design SCS  modifications  for conversion of the engine for
reliable heavy fuel use. SAIC will guide all Phase I  modifications  and testing
so that  the  technology  developed  will be able to meet all  requirements  and
specifications  in a  possible  Phase  II  development  effort.  Phase  II,  the
principal  research or development  effort,  would involve the  fabrication  and
delivery of a well-defined  operational prototype engine, with documentation and
demonstration  of its operational  performance  and ruggedness,  while Phase III
would  involve  transition of the  prototype  into a viable  product for sale in
military and/or private sector markets.

       The Company is exploring  additional  potential  uses by the military for
its heavy fuel engine technology,  such as in other UAV models and light-weight,
man-portable  generator  sets  used in the  field,  as well  as  private  sector
opportunities.  Operation  of a  light-weight  engine on a high flash point fuel
such as diesel,  rather than gasoline,  will reduce the hazard  associated  with
gasoline,  making  such an engine  much more  suitable  for  applications  where
gasoline  storage is undesirable,  such as in diesel fueled utility engines used
in pumps, generator sets, etc., in homes, commercial buildings and boats.

       As of June 30, 1998,  the Company had five  employees:  its two executive
officers and three individuals who provide  engineering and technical  services.
Additional  information  on the  Company's  business,  its  technology,  and its
management can be found in the Company's 1997 Annual Report on Form 10-KSB.


Financial position
- ------------------

       Since its  inception in 1980,  the Company has generated  cumulative  net
losses in excess of $20  million.  Operating  funds have been  raised  primarily
through the sale of equity  securities  in both  public and  private  offerings,
while revenues to date have not been significant.  Accordingly,  Sonex continues
to be classified as a development stage company.

       As of June 30, 1998,  the Company had available  cash and  equivalents of
approximately $265,000,  marketable securities valued at approximately $204,500,
and  receivables  from  the  U.S.  Government  of  approximately  $133,000.  The
marketable  securities represent holdings in the common stock of the corporation
which  in  October  1995  was  merged  with  and  into  the  Company's  inactive
subsidiary.  The fair  value of such  securities,  however,  may be  subject  to
significant fluctuation due to, among other factors,  limited trading volume and
a small public float.

       Based upon current and projected  spending  levels,  management  believes
that the currently  available  resources  and expected  revenue from current and
potential  contracts will be sufficient to fund operations at least through June
30, 1999. The Company is currently in negotiations  for technology  transfer and
licensing  agreements  which would  provide  substantial  operating  funds,  but
execution of such  agreements is not assured.  In the absence of the realization
of significant revenues,  additional capital may be necessary to fund operations
for 1999 and beyond.






                                     - 11 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


Results of operations
- ---------------------

      A net loss from  operations  of $227,356  was  recorded for the first six
months of 1998, as compared to $231,513 for the corresponding  period in 1997, a
decrease  of  $4,157.  The  decrease  in the loss  resulted  from the fact  that
increases of $72,667 in revenue and $22,519 in  investment  income  exceeded the
increase in total expenses of $91,029.

Revenue:

                                     Development               Sub-
                                      contracts              contracts

                      1998            $166,370               $ 50,672
                      1997            $144,375                   -

Development  contract  revenue and revenue  from  subcontracts  consisted of the
following amounts:

    o   $61,457 in 1998 pursuant to the continuing contract with the U.S. Naval
        Air Warfare Center to convert a gasoline fueled UAV engine to use heavy
        fuels;
    o   $7,148 in 1998 pursuant to the contract  with the USMC  completed in the
        first quarter to convert a gasoline fueled small UAV engine to use heavy
        fuels and,  through a subcontract  for which related  revenue of $13,272
        has been recorded in 1998, to upgrade the electronics in the UAV;
    o   $87,215 in 1998 pursuant to the recently executed contract with the USMC
        to  convert  an  additional  forty UAV  gasoline  engines  to heavy fuel
        operation, as well as related subcontract revenue of $37,400 for outside
        machining services;
    o   $90,000 in 1997 related to the delivery of  prototype  Sonex  pistons to
        a major international OEM;
    o   $40,000 in 1997 under a  demonstration program begun in 1996 to apply
        the SCS to a truck diesel engine for another major international OEM;
    o   $10,550 in 1998 and $14,375 in 1997 related to other small engine
        projects.


Research and development (R&D) expenses:

      R&D expenses  for the first six months of the year  increased by $38,158,
or 15%,  from  $249,967 in 1997 to $288,125 in 1998,  as  increases in personnel
costs of $40,175,  project  parts and  supplies of  $17,839,  and other  expense
categories  of a net of  $6,877  were  offset  in part by a  decrease  in patent
maintenance  fees and  amortization  of the  capitalized  costs of  patents  and
technology of $26,733.
     
     The  increase in the largest  expense  category,  personnel  costs,  from
$156,629  in  1997  to  $196,804  in  1998,   relates  almost  entirely  to  the
compensation  and  expenses  of a  consultant  who serves as the  Company's  R&D
supervisor and corporate  liaison in Europe.  Through the third quarter of 1997,
this  individual was  compensated  primarily in the form of restricted  stock or
stock options for services performed in Europe. In the fourth quarter of 1997, a
new agreement was executed  whereby for time spent in Annapolis he receives cash
compensation,  a portion of which is  deferred,  and for  services  performed in
Europe he is paid in the form of restricted  stock.  For the first six months of
1998, this individual  received  restricted stock valued at $18,462 for services
performed in Europe,  earned cash  compensation for time spent at Sonex totaling
$12,692,  of which  $5,077  has been  deferred,  and was  reimbursed  $7,631 for
travel,  lodging, and other business expenses.  Related charges for 1997 totaled
only  $1,500.  In  addition,  an increase of $5,120 for  temporary  help charges
incurred in 1998 was partially  offset by a decrease in  unemployment  taxes and
other employee benefits of $2,731.  Total salaries showed a net increase of only
$501.

       Project parts and supplies  increased  from $14,634 in 1997 to $32,473 in
1998 due to the increase in the number of funded  contracts,  particularly  with
respect to the small,  two-cycle  engine work for the military.  Related charges
for the first six months of 1998  totaled  $12,562,  while there were no similar
charges for the same period in 1997. The Company also incurred charges of $5,552
in 1998 for parts and  supplies  used in other  two-cycle  engine  research  not
performed under contract, but none in 1997.

       Patent  maintenance  fees and  amortization of the  capitalized  costs of
patents  and  technology  decreased  from  $41,174  in 1997 to  $14,441  in 1998
primarily as a result of a reduction in amortization  expense of $25,778, as the
capitalized  costs of computer  simulations  became fully amortized during 1997;
thus, there was no corresponding charge in 1998.



                                     - 12 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


Cost of sub-contracts:

      The Company's  demonstration contract with the USMC to convert a gasoline
fueled UAV  engine to use heavy  fuels also  included a  subcontract  to another
vendor for the upgrade of the electronics in the UAV. "Cost of  subcontracts" in
1998  includes  $12,420 in  connection  with this work,  as well as $35,200  for
outside machining  services pursuant to the contract with the USMC to convert an
additional  forty UAV gasoline  engines to heavy fuel  operation.  There were no
such charges in the same period in 1997.


General and administrative (G&A) expenses:

       G&A expenses for the first half of the year  increased by $5,823,  or 4%,
from  $142,568  in 1997 to  $148,391  in 1998,  primarily  as a result  of a net
increase in personnel costs of $6,180,  from $72,693 in 1997 to $78,873 in 1998.
The net increase in personnel costs consisted of an increase  resulting from the
recording of $22,322 in 1998 for  compensation  cost for the current  vesting of
stock options  granted in the fourth quarter of 1997 by the Company's  principal
shareholder  to the new president of the Company,  offset by a decrease in total
salaries of $14,000,  due primarily to a reduction  caused by the termination of
the  employment  as of the end of the  third  quarter  of 1997 of the  Company's
former president, who had been employed on a part-time basis.



























































                                     - 13 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB


                           PART II - OTHER INFORMATION


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

At the annual meeting of the Company's  security  holders held on June 16, 1998,
the holders of the Company's  Common Stock re-elected Dr. Andrew A. Pouring as a
director for a term  expiring at the annual  meeting  held in the year 2001.  No
other  matters were  submitted to a vote of security  holders  during the second
quarter of 1998.



ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K


  (a)    Exhibits:

           4      Instruments defining the rights of security holders (contained
                  in the  Articles of  Incorporation  and  By-laws,  as amended,
                  filed with the 1992 Annual Report on Form 10-KSB)

  (b)    Reports on Form 8-K:

                  None.




                                   SIGNATURES


         In accordance with the requirements of the Exchange Act, the Registrant
caused this report to be signed on its behalf by the  undersigned,  thereto duly
authorized.


                                 SONEX RESEARCH, INC.
                                  (Registrant)



                                            /s/ George E. Ponticas
                                         ----------------------------
                                by:      George E. Ponticas
                                         Chief Financial Officer


August 12, 1998

































                                     - 14 -
<PAGE>

<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         265,608
<SECURITIES>                                   204,500
<RECEIVABLES>                                  133,396
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               655,762
<PP&E>                                         424,807
<DEPRECIATION>                                 404,173
<TOTAL-ASSETS>                                 911,122
<CURRENT-LIABILITIES>                          769,054
<BONDS>                                              0
                                0
                                     15,400
<COMMON>                                       175,944
<OTHER-SE>                                     (49,276)
<TOTAL-LIABILITY-AND-EQUITY>                   911,122
<SALES>                                        217,042
<TOTAL-REVENUES>                               217,042     
<CGS>                                           47,620
<TOTAL-COSTS>                                  484,136
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (227,356)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (227,356)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (227,356)
<EPS-PRIMARY>                                    ($.01)
<EPS-DILUTED>                                    ($.01)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission